{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Vertex Pharmaceuticals and Eli Lilly are expected to announce today that they have developed a drug candidate that can attack the hepatitis C virus in the same way that several drugs attack H.I.V., the virus that causes AIDS. The companies say that their compound, which they hope to begin testing in patients in 2003, blocks an enzyme known as a protease, which the hepatitis C virus needs to replicate itself. Protease inhibitors for H.I.V. have had a significant effect in treating AIDS, and many companies have tried to develop one for hepatitis C.", "headline": {"main": "Announcement on a Hepatitis C Drug Is Expected Today"}, "abstract": null, "print_page": "2", "word_count": 640, "_id": "4fd25bb48eb7c8105d808ef6", "snippet": "Vertex Pharmaceuticals and Eli Lilly are expected to announce today that they have developed a drug candidate that can attack the hepatitis C virus in the same way that several drugs attack H.I.V., the virus that causes AIDS.    The companies say...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/01/07/business/announcement-on-a-hepatitis-c-drug-is-expected-today.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2002-01-07T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Money and Business/Financial Desk", "lead_paragraph": "HEALTH care funds have outperformed the overall market over the last decade, and despite a disappointing run last year, some of the funds' managers declare that the future is theirs. ''We believe this decade belongs to us,'' said Samuel Isaly, manager of the Eaton Vance Worldwide Health Sciences fund, the top-performing health care sector fund over the last 10 years, according to Morningstar. ''In my opinion, health and biotech stocks can dominate the market over the next decade, just as technology stocks did in the 1990's,'' he said.", "headline": {"main": "Managers Say This Decade Belongs to Health Care", "kicker": "MUTUAL FUNDS REPORT"}, "abstract": "Health care mutual fund managers predict sector, which outperformed overall market over last decade, despite disappointing 2001, will dominate market in next decade; health care sector funds fell average of 10.9 percent in 2001; returned 13.8 percent a year over last 10 years, versus 12.9 percent for Standard & Poor's 500-stock index; photo (M)", "print_page": "20", "word_count": 1245, "_id": "4fd229928eb7c8105d7b39eb", "snippet": "HEALTH care funds have outperformed the overall market over the last decade, and despite a disappointing run last year, some of the funds' managers declare that the future is theirs.    ''We believe this decade belongs to us,'' said Samuel Isaly,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/01/06/business/mutual-funds-report-managers-say-this-decade-belongs-to-health-care.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MUTUAL FUNDS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "STOCKS AND BONDS"}], "byline": {"person": [{"firstname": "Virginia", "middlename": "Munger", "lastname": "KAHN", "rank": 1, "role": "reported", "organization": ""}], "original": "By VIRGINIA MUNGER KAHN"}, "document_type": "article", "pub_date": "2002-01-06T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "After shrinking electronics into microelectronics and machines into micromachines, scientists have become microplumbers, too. By carving mazes of pipes the width of a human hair into silicon, glass and plastic, they have developed devices that shuttle around minuscule amounts of liquid, mix them together, run chemical experiments or analyze bits of DNA floating within. They are essentially condensing entire chemistry laboratories -- including the expertise of the technicians -- onto small chips, with the promise of the usual benefits of miniaturization: faster, cheaper, better.", "headline": {"main": "Scientists Find That Tiny Pipes Offer Big Payoffs"}, "abstract": "Technology known as microfluidics shuttles miniscule amounts of liquid around in tiny pipes etched on small chips, essentially creating miniature laboratory; first commercial products using microfluidics are on market, designed to sort snippets of DNA or screen thousands of potential drug compounds quickly and automatically, and researchers say field promises wide variety of applications; drawing (M)", "print_page": "1", "word_count": 1638, "_id": "4fd22ab68eb7c8105d7b5fc5", "snippet": "After shrinking electronics into microelectronics and machines into micromachines, scientists have become microplumbers, too.    By carving mazes of pipes the width of a human hair into silicon, glass and plastic, they have developed devices that...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/01/01/science/scientists-find-that-tiny-pipes-offer-big-payoffs.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "BIOLOGY AND BIOCHEMISTRY"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "DNA (DEOXYRIBONUCLEIC ACID)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Kenneth", "lastname": "CHANG"}], "original": "By KENNETH CHANG"}, "document_type": "article", "pub_date": "2002-01-01T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 3, "offset": 0, "time": 25}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}